Şunu aradınız:: livmoderhals celleforandringer (Danca - İngilizce)

livmoderhals
cervix

livmoderhals-adenokarcinom
adenocarcinoma in situ of the cervix

celleforandringer i livmoderhalsen
abnormal cells in your cervix

sammenkobling af klinisk effekt overfor anale celleforandringer og cancer
bridging of clinical efficacy against anal lesions and cancers

livmoder-, livmoderhals-, brystkræft og kræft i æggestokkene.
uterine, cervical, ovarian or breast cancer.

cervarix var mere effektiv end sammenligningsvaccinen til at forebygge celleforandringer i livmoderhalsen.
cervarix was more effective than the comparator vaccine in preventing abnormal cell growth in the cervix.

- celleforandringer i livmoderhalsen (med risiko for udvikling til kræft).
- precancerous cervical lesions (changes in cells of the cervix that have a risk of turning into

kvinder med svære celleforandringer eller manglende cytologi (0, 5%) blev ekskluderet fra effektanalyserne.
women with high-grade or missing cytology (0.5%) were excluded from the efficacy analysis.

der findes ingen oplysninger om beskyttelse mod persisterende infektion eller præmaligne celleforandringer blandt hiv-inficerede kvinder.
no information exists about protection against persistent infection or precancerous lesions among hiv infected women.

jeg vil gerne have lov til kort at gå videre til hele spørgsmålet om systematisk screening og tidlig diagnostik af livmoderhals- og brystkræft. i mit land har
it will only be honourable when we agree, when we say 'these are carcinogens and have to be banned, to protect both consumers and workers at the workplace'.

for så vidt angår livmoderhals-, tyktarms- og endetarmskræft, forhindrer diagnosticering af præcancerøse læsioner kræften i at brude ud.
how strange that we should be adopting or considering a proposal to adopt — and i hope we will not — those particular words, which come from a country where, quite frankly, everything has really gone haywire.

flere cin2+ celleforandringer indeholdt flere onkogene typer (inklusive ikke- vaccine hpv- typer).
several of the cin2+ lesions contained multiple oncogenic types (including non-vaccine hpv types).

som led i programmet » europa mod kræft « opfor drer kommissionen til systematisk screening og ret tidig diagnose af livmoderhals- og brystkræft.
croux (ppe). — (nl) mr president, we ask whether the quorum is present pursuant to rule 89. the reason that we are asking this is that there were 40 members present in this chamber at the previous vote.

cervarix beskytter ikke mod udvikling af hpv- relaterede celleforandringer hos kvinder, der er inficeret med hpv- 16 eller hpv- 18 på vaccinationstidspunktet.
cervarix does not prevent hpv-related lesions in women who are infected with hpv-16 or hpv-18 at the time of vaccination.

en supplerende analyse blev udført for at fastslå effekten af vaccine over for celleforandringer, som sandsynligvis var kausalt associeret med hpv- 16 og/ eller hpv- 18.
an additional analysis was conducted to determine vaccine efficacy against lesions likely to be causally associated with hpv-16 and/ or hpv-18.

vaccinen er derfor ikke indiceret til behandling af cervix- cancer, cervikal intraepitelialneoplasi (cin), eller andre hpv- relaterede celleforandringer.
the vaccine is therefore not indicated for treatment of cervical cancer, cervical intraepithelial neoplasia (cin) or any other established hpv- related lesions.

du skal fortsætte med at følge din læges råd om livmoderhalsundersøgelser (smear- test; en test som påviser evt. celleforandringer i livmoderhalsen forårsaget af en hpv- infektion), samt forebyggende og beskyttende forholdsregler.
you should continue to follow your doctor’ s advice on cervical smear/ pap test (test to screen for changes in cells of the cervix caused by an hpv infection) and preventative and protective measures.